Poster Session I – Poster of Distinction - A95 RESULTS OF A PROACTIVE REMOTE MONITORING QUALITY IMPROVEMENT (QI) INITIATIVE FOR PREGNANT PEOPLE WITH IBD

Abstract Background Inflammatory Bowel Disease (IBD) during pregnancy requires specialized care. As part of a quality improvement (QI) initiative administered at the Mount Sinai Hospital Preconception and Pregnancy in IBD Clinic, we implemented proactive remote disease monitoring to improve maternal outcomes. Aims 1) To evaluate whether interventions performed in trimester 2 reduced mental health and disease activity scores in trimester 3. 2) To compare the trimester 3 scores between participants who received trimester 2 interventions and those who did not. Methods Individuals with IBD under 27 weeks’ gestation were enrolled from August 2023 to September 2024 and were asked complete validated health status measurement tools per trimester and postpartum through an online dashboard. Responses that flagged increased disease activity (pMayo or mHBI), anxiety (GAD-7) or depressive symptoms (PHQ-9) triggered an intervention by an IBD nurse. Non-normal variables were summarized as medians (25th–75th%) and compared using Wilcoxon signed-rank tests for within-group analyses and Mann–Whitney U tests for between-group comparisons. A significance level of p < 0.05 was used. Results Among participants who received an intervention in trimester 2, median GAD-7 and PHQ-9 scores decreased by trimester 3 but were significant for PHQ-9 only (p<0.01). Between group comparisons at trimester 3 showed anxiety and depression scores remained significantly higher among those who received trimester 2 interventions (p<0.001 for both). Within group changes in pMayo increased for those who did not receive an intervention in trimester 2 (p=0.001) whereas a significant decrease was observed for those who did (p=0.039). No significant between group differences were observed for disease activity indicators (mHBI and pMayo) at trimester 3. Conclusions Proactive remote disease monitoring may help improve outcomes among pregnant IBD although further specialized mental health support amongst this population should be explored. Replication in larger in samples is recommended. Funding Agencies Science of Care Institute - Sinai Health

Authors

Institutions

Publication Details

Journal
Journal of the Canadian Association of Gastroenterology
Published
2026-02-01
DOI
https://doi.org/10.1093/jcag/gwaf042.095
Primary Topic
Pregnancy and Medication Impact
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Poster Session I – Poster of Distinction - A95 RESULTS OF A PROACTIVE REMOTE MONITORING QUALITY IMPROVEMENT (QI) INITIATIVE FOR PREGNANT PEOPLE WITH IBD

M Al-Asafen, K O’ Connor, M Harris, V W Huang et al.
Journal of the Canadian Association of Gastroenterology
Pregnancy and Medication Impact
article

Poster Session I – Poster of Distinction - A95 RESULTS OF A PROACTIVE REMOTE MONITORING QUALITY IMPROVEMENT (QI) INITIATIVE FOR PREGNANT PEOPLE WITH IBD

M Al-Asafen, K O’ Connor, M Harris, V W Huang, V Srikanth
article en

Abstract

Abstract Background Inflammatory Bowel Disease (IBD) during pregnancy requires specialized care. As part of a quality improvement (QI) initiative administered at the Mount Sinai Hospital Preconception and Pregnancy in IBD Clinic, we implemented proactive remote disease monitoring to improve maternal outcomes. Aims 1) To evaluate whether interventions performed in trimester 2 reduced mental health and disease activity scores in trimester 3. 2) To compare the trimester 3 scores between participants who received trimester 2 interventions and those who did not. Methods Individuals with IBD under 27 weeks’ gestation were enrolled from August 2023 to September 2024 and were asked complete validated health status measurement tools per trimester and postpartum through an online dashboard. Responses that flagged increased disease activity (pMayo or mHBI), anxiety (GAD-7) or depressive symptoms (PHQ-9) triggered an intervention by an IBD nurse. Non-normal variables were summarized as medians (25th–75th%) and compared using Wilcoxon signed-rank tests for within-group analyses and Mann–Whitney U tests for between-group comparisons. A significance level of p < 0.05 was used. Results Among participants who received an intervention in trimester 2, median GAD-7 and PHQ-9 scores decreased by trimester 3 but were significant for PHQ-9 only (p<0.01). Between group comparisons at trimester 3 showed anxiety and depression scores remained significantly higher among those who received trimester 2 interventions (p<0.001 for both). Within group changes in pMayo increased for those who did not receive an intervention in trimester 2 (p=0.001) whereas a significant decrease was observed for those who did (p=0.039). No significant between group differences were observed for disease activity indicators (mHBI and pMayo) at trimester 3. Conclusions Proactive remote disease monitoring may help improve outcomes among pregnant IBD although further specialized mental health support amongst this population should be explored. Replication in larger in samples is recommended. Funding Agencies Science of Care Institute - Sinai Health

Journal of the Canadian Association of GastroenterologyVol. 9(Supplement_1)
University of Toronto (CA)
Good health and well-being
Openalex Percentile: Top 58%
Pregnancy and Medication Impact
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.